NCT05849701

Brief Summary

This study will be a randomized, open-label, pretest post-test with two study groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

11 months

First QC Date

April 24, 2023

Last Update Submit

May 5, 2023

Conditions

Keywords

Shock wave therapyvacuum-assisted closureChronic diabetic foot ulcer

Outcome Measures

Primary Outcomes (2)

  • Wound surface area

    using the ruler method to to measure the longest length and the widest width and multiplying them.

    change from baseline and after six weeks of intervention.

  • Wound volume

    using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.

    change from baseline and after six weeks of intervention.

Secondary Outcomes (4)

  • Wound surface area

    change from baseline and after two weeks of intervention.

  • Wound surface area

    change from baseline and after four weeks of intervention.

  • Wound volume

    change from baseline and after two weeks of intervention.

  • Wound volume

    change from baseline and after four weeks of intervention.

Study Arms (2)

Shock wave therapy group

ACTIVE COMPARATOR

Patients in this group were managed by shock wave therapy, using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session, for six weeks

Device: Shock wave therapy

Vacuum-assisted closure group

ACTIVE COMPARATOR

the patients in this group were treated by vacuum-assisted closure using KCI's Vacuum Assisted Closure Device, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, The dressings were changed on the fourth day.

Device: Vacuum-assisted closure

Interventions

using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session for 6 weeks.

Also known as: Traditional medical and wound care
Shock wave therapy group

Using KCI's Vacuum Assisted Closure Device for six weeks, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, the dressings were changed on the fourth day.

Also known as: Traditional medical and wound care
Vacuum-assisted closure group

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients had chronic diabetic foot ulcers that did not heal within six weeks of the incidence.

You may not qualify if:

  • Patients with acute cellulitis, osteomyelitis, or gangrene anywhere in the affected extremity.
  • Patients with renal, hepatic, neurological, or malignant diseases.
  • Patients with severe protein malnutrition (serum albumin \< 2.0 g/dl) or severe anemia (Hgb \< 7.0 g/dl).
  • Patients with an ankle-brachial index \< 0.7, absence of the dorsalis pedis or posterior tibial artery pulse.
  • Patients who had debridement; pregnancy.
  • Patients who refused to join the study, or to sign the written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaimaa Mohamed Ahmed El Sayeh

Cairo, 02, Egypt

Location

MeSH Terms

Interventions

Extracorporeal Shockwave TherapyNegative-Pressure Wound Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitationDrainageSurgical Procedures, OperativeWound Closure Techniques

Study Officials

  • Shaimaa MA El Sayeh, PhD

    Lecturer at Faculty of Physical Therapy, Cairo University

    PRINCIPAL INVESTIGATOR
  • Nesrein A Abdel Rashed, PhD

    Assistant Professor at Faculty of Physical Therapy, Cairo University

    PRINCIPAL INVESTIGATOR
  • Hamada A Hamada, PhD

    Assistant Professor at Faculty of Physical Therapy, Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 9, 2023

Study Start

March 10, 2022

Primary Completion

February 14, 2023

Study Completion

April 15, 2023

Last Updated

May 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations